0001193805-23-001072.txt : 20230803
0001193805-23-001072.hdr.sgml : 20230803
20230803161213
ACCESSION NUMBER: 0001193805-23-001072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230801
FILED AS OF DATE: 20230803
DATE AS OF CHANGE: 20230803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marantz Jing L.
CENTRAL INDEX KEY: 0001834528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38942
FILM NUMBER: 231140112
MAIL ADDRESS:
STREET 1: C/O KRYSTAL BIOTECH, INC.
STREET 2: 2100 WHARTON STREET, SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001768224
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8589002660
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
e618810_4-jing.xml
X0508
4
2023-08-01
0
0001768224
Arcturus Therapeutics Holdings Inc.
ARCT
0001834528
Marantz Jing L.
C/O ARCTURUS THERAPEUTICS HOLDINGS INC.
10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO
CA
92121
1
0
0
0
0
Stock option (right to buy)
34.92
2023-08-01
4
A
0
11869
0.00
A
2033-08-01
Common Stock
11869
11869
D
Deferred Stock Units
2023-08-01
4
A
0
3131
0.00
A
Common Stock
3131
3131
D
Shares underlying the option vest monthly over a one year period from the date of grant; provided however, that the remaining unvested balance will vest and become fully exercisable at the Issuer's 2024 annual meeting of stockholders. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
Each deferred stock unit is economically equivalent to one share of the Issuer's common stock.
Shares underlying the deferred stock units shall vest at the Issuer's 2024 annual meeting of stockholders. The shares underlying the deferred stock units will be issued on (or as soon as reasonably practicable following) the earlier of the Reporting Person's separation from service or a change in ownership of the Issuer or a substantial portion of its assets or a change in effective control of the Issuer within the meaning of regulations issued under Section 409A of the Internal Revenue Code. This represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
/s/ Ilan Katz, attorney-in-fact
2023-08-03